Episode 54: New Peptide for Immune Support, Synthetic Bioregulator Update & More with Jean-Francois Tremblay from CanLab Research

<p>In this week’s episode, Nathalie chats with Jean-François Tremblay start the conversation with  LL37 – a powerful antimicrobial peptide naturally synthesized in humans.  They then move on to a new hybrid peptide bringing Thymosin Alpha 1 and LL37 – designed to potentially mitigate the natural cytotoxic effects of LL37.   They then move on to the synthetic versions of the bioregulator peptides produced by CanLab and correct a commonly held misconception about proper dosing levels.  The good news is that Bioregulators just became a lot more affordable!  We then move on to GHK…and much much more!</p> <p> </p> <p><strong>Meet This Week's Guest</strong></p> <p><span style="font-weight: 400;">Jean-Francois Tremblay is the owner of CanLab, a Montreal</span> <span style= "font-weight: 400;">based company that specializes in synthesizing and manufacturing peptides. J</span><span style= "font-weight: 400;">ean-François Tremblay is a regular guest on this podcast.  Jean-Francois studied Exercise Physiology, Biochemistry, and Pharmacy at UQAM.  He has been researching (in theory and in practice) peptides and SARMS since the 90’s and has been studying the theoretical basis of what peptides are and their practical applications in sports performance, anti-aging, and health in general. </span></p> <p> </p> <p><strong>Episode Sponsor</strong><span style= "font-weight: 400;">: </span> <strong>drinkHRW.com</strong> <span style="font-weight: 400;">To get the most out of any therapy it is crucial to address the foundations of health.  Molecular Hydrogen addresses  these foundations through its ability to help to manage reactive oxygen species (ROS), inflammation and improve metabolic balance.  I drink molecular hydrogen water every morning before anything else and have my clients do the same.  Anecdotally we have seen improvements in blood sugar control, pain from arthritis and even cognitive function in a Parkinson’s patient.  Ongoing research is demonstrating the many ways that molecular hydrogen can support human health.  </spa